Dare Bioscience, Inc

Dare Bioscience (NASDAQ: DARE) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for womens health. With eight potentially first-in-class womens health products in development, we are committed to bring to market differentiated products designed to expand treatment options, improve outcomes, and facilitate a better quality of life for women. Vaginal drug delivery is often the optimum delivery approach to achieve these objectives, and IVR technology has become one of our preferred investigational platforms. Our portfolio features innovative IVR technologies including our non-hormonal contraceptive Ovaprene, which we believe has the potential to disrupt the contraceptive landscape by...

Women's reproductive health,women's health,fertility,contraception,vaginal health,biotechnology,innovation,and contraception

Dare bioscience, inc operates in the Biotechnology research industry.

Dare bioscience, inc's revenue is 1m - 10m

Dare bioscience, inc has 11 - 50 employees.